The/DT
peroxisome/NN
proliferator-activated/JJ
receptor/NN
alpha/NN
(/(
PPARalpha/NN
)/)
ligand/NN
WY/NN
14,643/CD
does/VBZ
not/RB
interfere/VB
with/IN
leukotriene/NN
B4/NN
induced/JJ
adhesion/NN
of/IN
neutrophils/NNS
to/TO
endothelial/JJ
cells/NNS
./.

Peroxisome/NN
proliferator-activated/JJ
receptors/NNS
(/(
PPAR/NNS
)/)
control/VBP
discrete/JJ
genes/NNS
involved/VBN
in/IN
fatty/JJ
acid/NN
and/CC
lipid/NN
metabolism/NN
./.
=====
Recently/RB
,/,
it/PRP
was/VBD
suggested/VBN
that/IN
activation/NN
of/IN
the/DT
alpha/NN
isoform/NN
of/IN
PPAR/NNS
by/IN
the/DT
potent/JJ
proinflammatory/JJ
mediator/NN
leukotriene/NN
B4/NN
(/(
LTB4/NN
)/)
enhanced/VBD
degradation/NN
of/IN
this/DT
eicosanoid/NN
,/,
offersuggesting/VBG
a/DT
new/JJ
aspect/NN
of/IN
down-regulation/NN
of/IN
inflammation/NN
./.
=====
Here/RB
,/,
we/PRP
studied/VBD
whether/IN
PPARalpha/NN
activation/NN
(/(
by/IN
means/NNS
of/IN
the/DT
selective/JJ
agonist/NN
WY/NN
14,643/CD
)/)
of/IN
endothelial/JJ
cells/NNS
,/,
pivotal/JJ
in/IN
the/DT
regulation/NN
of/IN
inflammatory/JJ
responses/NNS
,/,
interfered/VBN
with/IN
LTB4/NN
induced/VBD
adhesion/NN
of/IN
PMN/NN
neutrophil/NN
granulocytes/NNS
in/FW
vitro/FW
./.
=====
When/WRB
endothelial/JJ
cells/NNS
were/VBD
treated/VBN
with/IN
WY/NN
14,643/CD
prior/RB
to/TO
activation/NN
with/IN
LTB4/NN
(/(
or/CC
fMLP/NN
,/,
IL-1beta/NN
or/CC
TNFalpha/NN
,/,
as/IN
controls/NNS
)/)
we/PRP
could/MD
not/RB
document/VB
any/DT
effect/NN
on/IN
the/DT
number/NN
of/IN
adhering/JJ
PMN/NN
or/CC
duration/NN
of/IN
the/DT
response/NN
./.
=====
Thus/RB
,/,
this/DT
study/NN
provides/VBZ
no/DT
evidence/NN
indicating/VBG
a/DT
regulatory/JJ
function/NN
of/IN
PPARalpha/NN
in/IN
LTB4/NN
induced/JJ
adhesive/JJ
interactions/NNS
between/IN
endothelial/JJ
cells/NNS
and/CC
neutrophils/NNS